INJECTABLE

ARACHITOL 3L INJ

ARACHITOL 3L INJ

By ABBOTT

Regular price ₹ 352.68
Sale price ₹ 352.68 Regular price M.R.P:
Tax included. Shipping calculated at checkout.
Pack - 1mL
Expires on or after: Feb, 2027

Best deal on the Internet

Prescription Required question

Title

Check Availability

Rapid 3-4 Day Delivery,Tiny Extra Fee!

  • AnimealPet Safe
  • AnimealBest Quality
  • AnimealFast Delivery
  • AnimealSecure Payment
View full details

Collapsible content

About Product

The Arachitol 3L IU Injection by Abbott India Ltd is a high-potency, intramuscular injectable formulation of Cholecalciferol (Vitamin D3) delivering 300,000 IU per ampoule, specifically indicated for the treatment and correction of clinically significant Vitamin D deficiency in dogs, cats, cattle, horses, pigs, and other companion or farm animals. Vitamin D deficiency is a widespread and frequently underdiagnosed condition in pets and livestock that undermines skeletal integrity, impairs calcium and phosphate metabolism, compromises immune function, and contributes to debilitating musculoskeletal disorders including rickets, osteomalacia, and hypocalcaemia. The Arachitol 3L IU Injection targets this deficiency at its root, delivering a therapeutic bolus of Cholecalciferol that rapidly restores serum Vitamin D3 levels and initiates the cascade of physiological processes necessary for proper bone mineralisation and calcium homeostasis. Manufactured by Abbott India Ltd, a global leader in pharmaceutical science with a presence in over 160 countries, this injectable formulation meets the exacting standards of safety, sterility, and bioavailability expected of a trusted clinical pharmaceutical product. Animeal is proud to offer the Arachitol 3L IU Injection as part of its veterinary pharmaceutical range for pet parents and animal care professionals who demand precision-grade nutritional therapy for their animals.

Ingredients:

Cholecalciferol (Vitamin D3), 300,000 IU (equivalent to 7.5 mg) per ampoule:

Cholecalciferol (Vitamin D3) is a fat-soluble secosteroid prohormone synthesised naturally in the skin upon exposure to ultraviolet-B radiation and obtained additionally from dietary sources. At the molecular level, Cholecalciferol undergoes a two-step hydroxylation process following administration. The first hydroxylation occurs in the hepatic parenchymal cells, converting Cholecalciferol to 25-hydroxyvitamin D3 (calcidiol), the primary circulating storage form of Vitamin D. The second and biologically decisive hydroxylation occurs in the proximal tubular cells of the kidneys, producing 1,25-dihydroxyvitamin D3 (calcitriol), the hormonally active metabolite. Calcitriol binds to the nuclear Vitamin D receptor (VDR) found in intestinal epithelial cells, osteoblasts, renal tubular cells, and immune cells, initiating transcriptional activity that upregulates the expression of calcium-binding proteins such as calbindin-D9k. This mechanism directly enhances the intestinal absorption of calcium and inorganic phosphate from the gut, increases renal tubular reabsorption of calcium, and regulates the activity of osteoblasts and osteoclasts to facilitate the deposition of calcium into the bone matrix. The end result is a measurable, dose-dependent increase in serum calcium and phosphate concentrations, restoration of appropriate bone mineralisation density, and correction of the skeletal deformities and metabolic disturbances associated with Vitamin D insufficiency.

Features and Benefits

Restores Serum Vitamin D3 Levels Rapidly with a...

Restores Serum Vitamin D3 Levels Rapidly with a Single Therapeutic Dose:
The 300,000 IU bolus delivered by a single ampoule of Arachitol 3L IU Injection is formulated to correct clinically significant Vitamin D deficiency in a rapid and measurable timeframe. The intramuscular route of administration bypasses the gastrointestinal tract entirely, circumventing issues of oral absorption variability that are particularly relevant in animals with malabsorption syndromes, gastrointestinal disease, or compromised hepatic function.

Supports Bone Mineralisation and Skeletal Integrity:
By restoring calcitriol-mediated signalling in osteoblasts, the Arachitol 3L IU Injection directly reinforces the deposition of calcium phosphate crystals (hydroxyapatite) into the collagen matrix of developing and remodelling bone tissue. This process is essential for the prevention and reversal of rickets in young animals and osteomalacia in adults, both of which manifest as painful, fragile, and structurally compromised skeletons.

Regulates Calcium and Phosphate Metabolism Systemically:
Calcitriol produced from the administered Cholecalciferol acts across multiple organ systems simultaneously, enhancing intestinal absorption of both calcium and phosphate, improving renal tubular reabsorption of calcium, and modulating parathyroid hormone (PTH) secretion to maintain serum mineral balance within healthy physiological ranges. This systemic regulation is critical for animals experiencing secondary hyperparathyroidism driven by chronic Vitamin D depletion.

Supports Immune Function and Cellular Health:
Vitamin D receptors are expressed on a wide range of immune cells, including macrophages, dendritic cells, and T-lymphocytes, and calcitriol plays an established modulatory role in innate and adaptive immune responses. Correcting Vitamin D deficiency through targeted injectable supplementation therefore supports broader immune competence, particularly in animals recovering from illness, surgery, or periods of nutritional compromise.

Preferred Injectable Solution for Animals with Oral Supplementation Limitations:
For animals that cannot reliably absorb or tolerate oral Vitamin D3 supplements due to chronic enteropathy, fat malabsorption, or post-surgical gastrointestinal dysfunction, the intramuscular injection route provides a guaranteed, bioavailable delivery of the therapeutic dose without dependence on intestinal function, making Arachitol 3L IU Injection the clinical solution of choice in such cases.

Usage and Applications

How to Use:Arachitol 3L IU Injection must be ad...

How to Use:

Arachitol 3L IU Injection must be administered exclusively by a qualified veterinarian or trained veterinary professional. This product is a prescription-only injectable and is not intended for self-administration by pet owners or caregivers under any circumstances. The injection is delivered via the intramuscular route, with the specific site of administration, dose volume, and frequency of administration determined by the attending veterinarian based on the animal's species, body weight, age, clinical condition, baseline serum Vitamin D levels, and the presence of any concurrent health conditions affecting hepatic or renal hydroxylation capacity. A single ampoule delivers 300,000 IU and should be used in one session; partially used ampoules must not be stored or reused. The attending veterinarian may prescribe the injection as a standalone loading dose or as part of a structured supplementation protocol in combination with oral Vitamin D3 maintenance therapy. Regular monitoring of serum calcium and Vitamin D levels is recommended throughout the course of treatment to avoid toxicity from Vitamin D accumulation, as cholecalciferol is a fat-soluble compound with a prolonged biological half-life. Inform your veterinarian of all concurrent medications your animal is receiving, as interactions with cardiac glycosides, thiazide diuretics, and certain antifungal agents are clinically relevant.

Storage Advice:

Store unopened Arachitol 3L IU Injection ampoules in a cool, dry place below 25 degrees C, away from direct sunlight and sources of heat or moisture. Do not freeze. Once the ampoule is opened, the entire contents must be used immediately and any remaining solution must be discarded; opened ampoules may not be resealed or stored for later use. Keep ampoules in their original packaging until the point of use to protect the contents from light degradation. Do not use after the best-before date printed on the ampoule or outer carton.

About the Brand:

Abbott Laboratories was founded in 1888 by Dr. Wallace Calvin Abbott, a practising physician in Chicago who pioneered the formulation of active alkaloid medicinal compounds into precise, reliable dosage forms, making Abbott one of the founding forces in the scientific practice of modern pharmacy. With a presence today across more than 160 countries and a portfolio spanning pharmaceuticals, diagnostics, nutrition, and medical devices, Abbott operates to the highest international standards of pharmaceutical manufacturing and regulatory compliance, including its Indian subsidiary Abbott India Ltd, which has served the Indian healthcare market since 1910 and is publicly listed and headquartered in Mumbai. Abbott's commitment to translating rigorous science into trusted clinical solutions, backed by manufacturing facilities in Goa, Baddi, and Gujarat and dedicated research and development infrastructure, aligns with Animeal's commitment to offering only the most credible, efficacious, and vetted pharmaceutical products to the animals in your care. Discover Abbott today.

Disclaimer:

Please note that while Arachitol 3L IU Injection is formulated from pharmaceutical-grade Cholecalciferol (Vitamin D3) at 300,000 IU and is appropriate for use in dogs, cats, cattle, horses, pigs, and other companion and farm animals under veterinary supervision, it is a prescription-only injectable pharmaceutical and must not be purchased, stored, or administered without a valid veterinary prescription and direct veterinary oversight. This product is not a complete nutritional solution and does not replace a balanced, species-appropriate diet; it is indicated specifically for the targeted correction of clinically diagnosed Vitamin D deficiency and associated metabolic or skeletal conditions. Overdosage of Cholecalciferol is associated with serious adverse effects including hypercalcaemia, nephrocalcinosis, and soft tissue calcification, and this product must not be used in animals with pre-existing hypercalcaemia, hypervitaminosis D, kidney stones, or nephrocalcinosis. For pets with kidney disease, liver disease, cardiovascular conditions, or those that are pregnant or lactating, consult your veterinarian before introducing this product. Animeal supports your pet's health and happiness journey but does not replace the advice of a qualified veterinary professional.

Frequently Asked Questions

Which animals and life stages is the Arachitol 3L IU Injection suitable for?

The Arachitol 3L IU Injection is suitable for a range of species including dogs, cats, cattle, horses, and pigs, and may be used across life stages including puppies, kittens, adult animals, and seniors when prescribed by a veterinarian. It is not recommended for use in pregnant or lactating animals without explicit veterinary guidance, as high-dose Vitamin D3 carries the risk of adverse effects on fetal development and neonatal calcium regulation.

How frequently should this injection be administered to my pet?

The frequency of administration is determined entirely by your veterinarian based on the severity of Vitamin D deficiency confirmed by serum diagnostic testing, the animal's species, body weight, and overall health status. Typically, a single loading dose is administered, followed by monitoring of serum calcium and Vitamin D levels before any repeat dosing is considered. Your veterinarian may complement the injectable dose with an oral Vitamin D3 maintenance protocol thereafter.

How effective is the Arachitol 3L IU Injection in treating Vitamin D deficiency and related bone disorders?

Intramuscular Cholecalciferol injection is among the most reliable and clinically validated methods of correcting significant Vitamin D deficiency, particularly in animals where oral supplementation is insufficient or impractical. By bypassing gastrointestinal absorption variability, the injectable route delivers a guaranteed therapeutic dose that is converted by the liver and kidneys into the biologically active form calcitriol, which then directly restores calcium absorption, bone mineralisation, and systemic mineral balance. Measurable improvements in serum calcium and 25-hydroxyvitamin D levels are typically observed within weeks of administration.

Are there any side effects or safety concerns associated with this injection?

When administered at veterinarian-prescribed doses, Arachitol 3L IU Injection is generally well tolerated. However, as Cholecalciferol is a fat-soluble vitamin that accumulates in adipose and hepatic tissue, overdosage or excessively frequent administration can result in Vitamin D toxicity, manifesting as hypercalcaemia, excessive thirst, increased urination, vomiting, weakness, and in severe cases, calcification of soft tissues and kidney damage. Regular monitoring of serum calcium levels during treatment is essential. Animals with pre-existing kidney or liver disease require particularly careful dosing and monitoring.

What makes the Arachitol 3L IU Injection preferable to oral Vitamin D3 supplements for treating deficiency?

The defining advantage of the Arachitol 3L IU Injection over oral Vitamin D3 formulations lies in its route of delivery. Oral Vitamin D3 depends on intact fat absorption in the small intestine, which is significantly compromised in animals with malabsorption disorders, inflammatory bowel disease, post-surgical gastrointestinal conditions, or chronic pancreatitis. The intramuscular injection delivers the therapeutic dose directly into the muscular tissue for systemic absorption, completely bypassing the gut and ensuring that the full 300,000 IU reaches the circulation regardless of the animal's digestive health. This makes it the preferred clinical option for patients where oral supplementation has proven inadequate or unreliable.